在儿科脏移植期间,德克斯梅德托米丁的血液动力效应
Matéo Monteil1, Alexis Chenouard2, Gwenaëlle Roussey3
1Department of Pediatric Intensive Care Unit, Children's Hospital, Nantes University Hospital, 44000, Hôpital Femme-Enfant-Adolescent - CHU de Nantes, 38 Bd Jean Monnet, 44093, Nantes, France. mateo.monteil@chu-nantes.fr.
Pediatric nephrology (Berlin, Germany)
|September 4, 2024
概括
在儿科移植接受者 (pKTR) 中,外科用德克斯梅德托米丁增加了平均动脉压,改善了移植功能. 需要进一步的研究,以在更大的研究中证实这些发现.
科学领域:
- 麻醉学 麻醉学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 儿科手术 儿科手术
背景情况:
- 德克斯梅德托米丁越来越多地用于在全身麻醉期间的血液动力学稳定.
- 关于其在儿科移植接受者 (pKTR) 中使用的数据有限.
- 这项研究研究了德克斯梅德托米丁在pKTR中的外科手术期间的血液动力学影响.
研究的目的:
- 评估德克斯梅德托米丁在儿科患者的移植期间的血液动力学效应.
- 评估德克斯梅德托米丁在移植后对移植功能的影响.
主要方法:
- 在南特大学医院进行的回顾性研究 (2019-2023年).
- 在pKTR中比较手术内血动力学 (MAP,HR) 接受德克塞米丁 (DEX组) 与未接受德克塞米丁 (无DEX组) 的患者.
- 分析了移植功能 (肌素,GFR),流体使用和血管活性药物管理.
主要成果:
- 分析了DEX组的10名患者和没有DEX组的28名患者.
- 在DEX组 (p=0.039) 中,手术内平均动脉压 (MAP) 较高.
- 在DEX组中移植后1个月显著增加淋巴膜过率 (GFR) (p=0.009).
结论:
- 在pKTR中,手术期间使用的德克斯梅德托米丁与更高的外科手术期间MAP相关.
- 德克斯梅德托米丁的使用与1个月后的高级移植功能相关.
- 需要进行前性研究来证实这些发现.
相关概念视频
01:24Parenteral Anesthetics: Overview
111
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
111
01:21Skeletal Muscle Relaxants: Adverse Effects
348
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
348
01:11Renal Failure: Dose Adjustments
69
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
69
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K